{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T10:36:12Z","timestamp":1771583772977,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Chinese National Key Technology R&D Program, Ministry of Science and Technology","award":["2017YFC0907601"],"award-info":[{"award-number":["2017YFC0907601"]}]},{"name":"the Chinese National Key Technology R&D Program, Ministry of Science and Technology","award":["2017YFC0907605"],"award-info":[{"award-number":["2017YFC0907605"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-005"],"award-info":[{"award-number":["2021-I2M-1-005"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2022-I2M-1-004"],"award-info":[{"award-number":["2022-I2M-1-004"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2023-I2M-2-005"],"award-info":[{"award-number":["2023-I2M-2-005"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2023-I2M-C&T-B-018"],"award-info":[{"award-number":["2023-I2M-C&T-B-018"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-227"],"award-info":[{"award-number":["2022-PUMCH-A-227"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-013"],"award-info":[{"award-number":["2022-PUMCH-B-013"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2025-PUMCH-D-001"],"award-info":[{"award-number":["2025-PUMCH-D-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10067-025-07838-6","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:19:24Z","timestamp":1768994364000},"page":"1753-1763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for disease progression in primary Sj\u00f6gren's syndrome patients with low disease activity: a multicenter registry-based cohort study"],"prefix":"10.1007","volume":"45","author":[{"given":"Xiangpeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1326-1922","authenticated-orcid":false,"given":"Xiaomei","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"7838_CR1","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H et al (2016) Sj\u00f6gren syndrome. Nat Rev Dis Primers 2:16047. https:\/\/doi.org\/10.1038\/nrdp.2016.47","journal-title":"Nat Rev Dis Primers"},{"key":"7838_CR2","doi-asserted-by":"publisher","first-page":"e3821","DOI":"10.1136\/bmj.e3821","volume":"344","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, Bosch X (2012) Primary Sjogren syndrome. BMJ 344:e3821. https:\/\/doi.org\/10.1136\/bmj.e3821","journal-title":"BMJ"},{"key":"7838_CR3","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R (2015) Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74:1983\u20131989. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205375","journal-title":"Ann Rheum Dis"},{"key":"7838_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/clep.S47399","volume":"6","author":"R Patel","year":"2014","unstructured":"Patel R, Shahane A (2014) The epidemiology of Sj\u00f6gren\u2019s syndrome. Clin Epidemiol 6:247\u2013255. https:\/\/doi.org\/10.2147\/clep.S47399","journal-title":"Clin Epidemiol"},{"key":"7838_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","volume":"20","author":"M Beydon","year":"2024","unstructured":"Beydon M, McCoy S, Nguyen Y, Sumida T, Mariette X, Seror R (2024) Epidemiology of Sj\u00f6gren syndrome. Nat Rev Rheumatol 20:158\u2013169. https:\/\/doi.org\/10.1038\/s41584-023-01057-6","journal-title":"Nat Rev Rheumatol"},{"key":"7838_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Bombardieri S et al (2020) EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis 79:3\u201318. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216114","journal-title":"Ann Rheum Dis"},{"key":"7838_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41584-021-00634-x","volume":"17","author":"R Seror","year":"2021","unstructured":"Seror R, Nocturne G, Mariette X (2021) Current and future therapies for primary Sj\u00f6gren syndrome. Nat Rev Rheumatol 17:475\u2013486. https:\/\/doi.org\/10.1038\/s41584-021-00634-x","journal-title":"Nat Rev Rheumatol"},{"key":"7838_CR8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/s0140-6736(24)01433-8","volume":"404","author":"S Colafrancesco","year":"2024","unstructured":"Colafrancesco S, Priori R (2024) Sj\u00f6gren\u2019s disease: a new era for clinical trials? Lancet 404:498\u2013499. https:\/\/doi.org\/10.1016\/s0140-6736(24)01433-8","journal-title":"Lancet"},{"key":"7838_CR9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/s0140-6736(24)01211-x","volume":"404","author":"BA Fisher","year":"2024","unstructured":"Fisher BA, Mariette X, Papas A et al (2024) Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sj\u00f6gren\u2019s disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study. Lancet 404:540\u2013553. https:\/\/doi.org\/10.1016\/s0140-6736(24)01211-x","journal-title":"Lancet"},{"key":"7838_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/annrheumdis-2024-eular.LBA90","volume":"83","author":"JE Gottenberg","year":"2024","unstructured":"Gottenberg JE, Sivils K, Campbell K et al (2024) LBA0010 efficacy and safety of nipocalimab, an anti-FcRn monoclonal antibody, in primary Sjogren\u2019s disease: results from a phase 2, multicenter, randomized, placebo-controlled, double-blind study (DAHLIAS). Ann Rheum Dis 83:240. https:\/\/doi.org\/10.1136\/annrheumdis-2024-eular.LBA90","journal-title":"Ann Rheum Dis"},{"key":"7838_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12891-017-1543-z","volume":"18","author":"SQ Wang","year":"2017","unstructured":"Wang SQ, Zhang LW, Wei P, Hua H (2017) Is hydroxychloroquine effective in treating primary Sjogren\u2019s syndrome: a systematic review and meta-analysis. BMC Musculoskelet Disord 18:186. https:\/\/doi.org\/10.1186\/s12891-017-1543-z","journal-title":"BMC Musculoskelet Disord"},{"key":"7838_CR12","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s10067-015-3003-1","volume":"34","author":"M Li","year":"2015","unstructured":"Li M, Tian X, Zhang W, Leng X, Zeng X (2015) CRDC: a Chinese rheumatology research platform. Clin Rheumatol 34:1347\u20131352. https:\/\/doi.org\/10.1007\/s10067-015-3003-1","journal-title":"Clin Rheumatol"},{"key":"7838_CR13","doi-asserted-by":"publisher","first-page":"e15284","DOI":"10.1111\/1756-185x.15284","volume":"27","author":"L Yueting","year":"2024","unstructured":"Yueting L, Lin Q, Jian X et al (2024) Long-term survival analysis of patients with primary Sj\u00f6gren\u2019s syndrome in China: a multicenter retrospective cohort study. Int J Rheum Dis 27:e15284. https:\/\/doi.org\/10.1111\/1756-185x.15284","journal-title":"Int J Rheum Dis"},{"key":"7838_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10067-022-06426-2","volume":"42","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Qiao L, Zhang L et al (2023) Renal tubular acidosis and associated factors in patients with primary Sj\u00f6gren\u2019s syndrome: a registry-based study. Clin Rheumatol 42:431\u2013441. https:\/\/doi.org\/10.1007\/s10067-022-06426-2","journal-title":"Clin Rheumatol"},{"key":"7838_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s10238-025-01715-x","volume":"25","author":"Y Li","year":"2025","unstructured":"Li Y, Chen S, Guo L et al (2025) Is high IgG level associated with disease activity and organ damage in patients with Sj\u00f6gren\u2019s syndrome? A 3-year follow-up cohort study. Clin Exp Med 25:174. https:\/\/doi.org\/10.1007\/s10238-025-01715-x","journal-title":"Clin Exp Med"},{"key":"7838_CR16","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1007\/s10067-020-04992-x","volume":"39","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li M, Zhang L et al (2020) Association between comorbidities and extraglandular manifestations in primary Sj\u00f6gren\u2019s syndrome: a multicenter cross-sectional study. Clin Rheumatol 39:2677\u20132688. https:\/\/doi.org\/10.1007\/s10067-020-04992-x","journal-title":"Clin Rheumatol"},{"key":"7838_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","volume":"75","author":"R Seror","year":"2016","unstructured":"Seror R, Bootsma H, Saraux A et al (2016) Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren\u2019s syndrome with EULAR primary Sj\u00f6gren\u2019s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 75:382\u2013389. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206008","journal-title":"Ann Rheum Dis"},{"key":"7838_CR18","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ et al (2010) EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis 69:1103\u20131109. https:\/\/doi.org\/10.1136\/ard.2009.110619","journal-title":"Ann Rheum Dis"},{"key":"7838_CR19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","volume":"74","author":"R Seror","year":"2015","unstructured":"Seror R, Theander E, Brun JG et al (2015) Validation of EULAR primary Sj\u00f6gren\u2019s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 74:859\u2013866. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204615","journal-title":"Ann Rheum Dis"},{"key":"7838_CR20","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X et al (2011) EULAR Sjogren\u2019s syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjogren\u2019s syndrome. Ann Rheum Dis 70:968\u2013972. https:\/\/doi.org\/10.1136\/ard.2010.143743","journal-title":"Ann Rheum Dis"},{"key":"7838_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1365-2362.2010.02303.x","volume":"40","author":"A Campar","year":"2010","unstructured":"Campar A, Isenberg DA (2010) Primary Sj\u00f6gren\u2019s syndrome activity and damage indices comparison. Eur J Clin Invest 40:636\u2013644. https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02303.x","journal-title":"Eur J Clin Invest"},{"key":"7838_CR22","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1093\/rheumatology\/keq086","volume":"49","author":"L Krylova","year":"2010","unstructured":"Krylova L, Isenberg D (2010) Assessment of patients with primary Sj\u00f6gren\u2019s syndrome\u2013outcome over 10 years using the Sj\u00f6gren\u2019s Syndrome Damage Index. Rheumatology (Oxford) 49:1559\u20131562. https:\/\/doi.org\/10.1093\/rheumatology\/keq086","journal-title":"Rheumatology (Oxford)"},{"key":"7838_CR23","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/s2665-9913(23)00099-1","volume":"5","author":"GM de Fr\u00e9mont","year":"2023","unstructured":"de Fr\u00e9mont GM, Costedoat-Chalumeau N, Lazaro E et al (2023) Pregnancy outcomes in women with primary Sj\u00f6gren\u2019s syndrome: an analysis of data from the multicentre, prospective, GR2 study. Lancet Rheumatol 5:e330\u2013e340. https:\/\/doi.org\/10.1016\/s2665-9913(23)00099-1","journal-title":"Lancet Rheumatol"},{"key":"7838_CR24","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba AC, Agoritsas T, Walsh M et al (2017) Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature. JAMA 318:1377\u20131384. https:\/\/doi.org\/10.1001\/jama.2017.12126","journal-title":"JAMA"},{"key":"7838_CR25","doi-asserted-by":"publisher","first-page":"e078276","DOI":"10.1136\/bmj-2023-078276","volume":"386","author":"O Efthimiou","year":"2024","unstructured":"Efthimiou O, Seo M, Chalkou K, Debray T, Egger M, Salanti G (2024) Developing clinical prediction models: a step-by-step guide. BMJ 386:e078276. https:\/\/doi.org\/10.1136\/bmj-2023-078276","journal-title":"BMJ"},{"key":"7838_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13226840","author":"\u00dc Uzeli","year":"2024","unstructured":"Uzeli \u00dc, Do\u011fan AG, \u015eahin T (2024) The relationship between systemic immune inflammatory level and dry eye in patients with Sj\u00f6gren\u2019s syndrome. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13226840","journal-title":"J Clin Med"},{"key":"7838_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5935\/0004-2749.20190005","volume":"82","author":"D Ozek","year":"2019","unstructured":"Ozek D, Kemer OE, Omma A (2019) Association between systemic activity \u0131ndex and dry eye severity in patients with primary Sj\u00f6gren syndrome. Arq Bras Oftalmol 82:45\u201350. https:\/\/doi.org\/10.5935\/0004-2749.20190005","journal-title":"Arq Bras Oftalmol"},{"key":"7838_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12886-025-04050-7","volume":"25","author":"Y He","year":"2025","unstructured":"He Y, Feng J, Shi W et al (2025) Correlation among ocular surface changes and systemic hematologic indexes and disease activity in primary Sj\u00f6gren\u2019s syndrome: a cross-sectional study. BMC Ophthalmol 25:270. https:\/\/doi.org\/10.1186\/s12886-025-04050-7","journal-title":"BMC Ophthalmol"},{"issue":"Suppl 126","key":"7838_CR29","first-page":"116","volume":"38","author":"J Narvaez","year":"2020","unstructured":"Narvaez J, S\u00e1nchez-Piedra C, Fern\u00e1ndez-Castro M et al (2020) Clinically significant renal involvement in primary Sj\u00f6gren\u2019s syndrome is associated with important morbidity: data from the Spanish Sj\u00f6grenser cohort. Clin Exp Rheumatol 38(Suppl 126):116\u2013124","journal-title":"Clin Exp Rheumatol"},{"key":"7838_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/nrneph.2015.174","volume":"12","author":"H Fran\u00e7ois","year":"2016","unstructured":"Fran\u00e7ois H, Mariette X (2016) Renal involvement in primary Sj\u00f6gren syndrome. Nat Rev Nephrol 12:82\u201393. https:\/\/doi.org\/10.1038\/nrneph.2015.174","journal-title":"Nat Rev Nephrol"},{"key":"7838_CR31","doi-asserted-by":"publisher","first-page":"e001033","DOI":"10.1136\/rmdopen-2019-001033","volume":"5","author":"S Abbara","year":"2019","unstructured":"Abbara S, Seror R, Henry J et al (2019) Anti-RNP positivity in primary Sj\u00f6gren\u2019s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. RMD Open 5:e001033. https:\/\/doi.org\/10.1136\/rmdopen-2019-001033","journal-title":"RMD Open"},{"key":"7838_CR32","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/s10067-025-07499-5","volume":"44","author":"F Cheng","year":"2025","unstructured":"Cheng F, Wang YL, Ai XY, Liu Y, Zhu ZH, Zhang KK, Zhao FT (2025) Clinical features of anti-RNP-positive primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol 44:2911\u20132917. https:\/\/doi.org\/10.1007\/s10067-025-07499-5","journal-title":"Clin Rheumatol"},{"key":"7838_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/096120339500400106","volume":"4","author":"P Zufferey","year":"1995","unstructured":"Zufferey P, Meyer OC, Bourgeois P, Vayssairat M, Kahn MF (1995) Primary systemic Sj\u00f6gren syndrome (SS) preceding systemic lupus erythematosus: a retrospective study of 4 cases in a cohort of 55 SS patients. Lupus 4:23\u201327. https:\/\/doi.org\/10.1177\/096120339500400106","journal-title":"Lupus"},{"key":"7838_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/096120339500400113","volume":"4","author":"M Satoh","year":"1995","unstructured":"Satoh M, Yamagata H, Watanabe F, Nakayama S, Ogasawara T, Tojo T, Akizuki M (1995) Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in an elderly woman with long-standing Sj\u00f6gren\u2019s syndrome. Lupus 4:63\u201365. https:\/\/doi.org\/10.1177\/096120339500400113","journal-title":"Lupus"},{"key":"7838_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.autrev.2010.05.004","volume":"9","author":"AL Fauchais","year":"2010","unstructured":"Fauchais AL, Martel C, Gondran G et al (2010) Immunological profile in primary Sj\u00f6gren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev 9:595\u2013599. https:\/\/doi.org\/10.1016\/j.autrev.2010.05.004","journal-title":"Autoimmun Rev"},{"key":"7838_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/rheumatology\/keae152","volume":"64","author":"EJ Price","year":"2024","unstructured":"Price EJ, Benjamin S, Bombardieri M et al (2024) British Society for Rheumatology guideline on management of adult and juvenile onset Sj\u00f6gren disease. Rheumatology 64:409\u2013439. https:\/\/doi.org\/10.1093\/rheumatology\/keae152","journal-title":"Rheumatology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07838-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07838-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07838-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:53:19Z","timestamp":1771581199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07838-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7838"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07838-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have disclosed no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}